Home > Healthcare > Pharmaceuticals > Finished Drug Form > Anticoagulants Market
Anticoagulants Market Share
- Report ID: GMI4967
- Published Date: Jun 2023
- Report Format: PDF
Anticoagulants Market Share
- Bayer AG
- Johnson and Johnson
- Amphastar Pharmaceuticals, Inc.
- Shenzhen Hepalink
- Leo Pharma
- Boehringer Ingelheim
- Daiichi Sankyo Company
- Sanofi
- Pfizer
Frequently Asked Questions (FAQ) :
The market size of anticoagulants was valued at around USD 39.2 billion In 2022 and will grow at over 9.5% CAGR from 2023 to 2032, attributed to the rising occurrence of chronic disorders globally.
Based on the drug category, industry size from the Factor Xa inhibitor segment will be worth about USD 58.4 billion by 2032, owing to its high availability.
North America market anticoagulants accounted for over 60.5% of the industry share in 2022, on account of rising healthcare spending in the region.
Major anticoagulants industry players include Johnson and Johnson, Boehringer Ingelheim, Daiichi Sankyo Company, Sanofi, Shenzhen Hepalink, Amphastar Pharmaceuticals, Inc., and Pfizer, among others.
Anticoagulants Market Scope
×
Get a free sample of
Anticoagulants Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below